adalimumab
Phase 1- Indications
- Autoimmune diseases
Company intelligence / Profile preview
Minapharm Pharmaceuticals
Cairo, Greater Cairo, Egyptminapharm.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Minapharm develops, manufactures and commercializes over 150 life-saving and life-enhancing products ranging from small molecules to complex genetically engineered proteins
- Therapeutic areas
- GastroenterologyCardiovascularNephrologyOphthalmologyEndocrinologyImmunologyDermatologyWomen's HealthHematologyNeurologyInfectious Diseases
- Modalities
- Small moleculesBioengineered proteinsRecombinant proteinsCell and gene therapiesVaccines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Cheerland Biotechnology (CLB)
Beyond the preview
Go deeper on Minapharm Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Minapharm Pharmaceuticals.